|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-1-23
|
|
pubmed:abstractText |
This single-institution Phase III study conducted from 1989 to 1995 evaluates the feasibility of a multimodality protocol combining hyperfractionated craniospinal radiotherapy (HFRT) followed by adjuvant chemotherapy in 23 patients with newly diagnosed primitive neuroectodermal tumors (PNET) arising in the central nervous system.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1155-61
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8985038-Adolescent,
pubmed-meshheading:8985038-Adult,
pubmed-meshheading:8985038-Brain Neoplasms,
pubmed-meshheading:8985038-Chemotherapy, Adjuvant,
pubmed-meshheading:8985038-Child,
pubmed-meshheading:8985038-Child, Preschool,
pubmed-meshheading:8985038-Combined Modality Therapy,
pubmed-meshheading:8985038-Cranial Irradiation,
pubmed-meshheading:8985038-Female,
pubmed-meshheading:8985038-Humans,
pubmed-meshheading:8985038-Male,
pubmed-meshheading:8985038-Medulloblastoma,
pubmed-meshheading:8985038-Neuroectodermal Tumors, Primitive,
pubmed-meshheading:8985038-Pilot Projects,
pubmed-meshheading:8985038-Radiotherapy
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
|
|
pubmed:affiliation |
Division of Neuro-Oncology, The Kaplan Comprehensive Cancer Center, NYU Medical Center, New York, NY, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
